Wenzl, F. A., Wang, P., Kahles, F., Beck, K. R., Giannitsis, E., Obeid, S., . . . Lüscher, T. F. (2025). Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease. European heart journal. https://doi.org/10.1093/eurheartj/ehaf661
Chicago-Zitierstil (17. Ausg.)Wenzl, Florian A., et al. "Gut Microbiota-derived Imidazole Propionate Predicts Cardiometabolic Risk in Patients with Coronary Artery Disease." European Heart Journal 2025. https://doi.org/10.1093/eurheartj/ehaf661.
MLA-Zitierstil (9. Ausg.)Wenzl, Florian A., et al. "Gut Microbiota-derived Imidazole Propionate Predicts Cardiometabolic Risk in Patients with Coronary Artery Disease." European Heart Journal, 2025, https://doi.org/10.1093/eurheartj/ehaf661.